L R Salgado

High variability in baseline urinary free cortisol values in patients with Cushing's disease

Stephan Petersenn, John Newell‐Price, James W. Findling et al. · Clinical Endocrinology · 2013 · 143 citations · Full text

Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase <scp>III</scp> study

Rosario Pivonello, Stephan Petersenn, John Newell‐Price et al. · Clinical Endocrinology · 2014 · 116 citations

Treatment of acromegaly with octreotide‐LAR: extensive experience in a Brazilian institution

Raquel S. Jallad, Nina Rosa de Castro Musolino, L R Salgado et al. · Clinical Endocrinology · 2005 · 87 citations

Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing’s disease: results from an open-ended, open-label extension trial

Jochen Schopohl, Feng Gu, R.D. Rubens et al. · Pituitary · 2014 · 62 citations · Full text

Long-term treatment of Cushing’s disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial

Stephan Petersenn, L R Salgado, Jochen Schopohl et al. · Endocrine · 2017 · 59 citations · Full text